Environmental factors involved in carcinogenesis of urothelial cell carcinomas of the upper urinary tract - PubMed (original) (raw)
Review
Environmental factors involved in carcinogenesis of urothelial cell carcinomas of the upper urinary tract
Pierre Colin et al. BJU Int. 2009 Nov.
Abstract
Primary cancers of the ureter and renal pelvis are rare tumours, > 90% of which are transitional cell carcinomas. Only approximately 5% of urothelial tumours arise in the upper urinary tract (UUT). Many environmental factors contribute to the development of these cancers. Some are similar to bladder cancer-associated factors (tobacco, occupational exposure), while others are more specific to carcinogenesis of the UUT (phenacetine, Balkan endemic nephropathy [BEN], Chinese herb nephropathy or association with Blackfoot disease [BFD]). This review discusses the environmental factors involved in UUT carcinoma. Tobacco and occupational exposure remain the principal exogenous risk factors for developing these tumours. Conversely, carcinogenesis of UUT tumours resulting from phenacetine consumption has almost disappeared. Although the incidence of BEN is also on the decline, roles for aristolochic acid and the consumption of Chinese herbs in the physiopathology and induction of this nephropathy, respectively, have proposed. In Taiwan, the association of this tumour type with BFD and arsenic exposure remains unclear to date. As some genetic polymorphisms are associated with an increased risk of cancer or faster disease progression, there is variability in interindividual susceptibility to the development of UUT carcinoma when exposed to the aforementioned risk factors Cytosolic sulfotransferases (SULTs) catalyse the detoxification of many environmental chemicals but also in the bioactivation of dietary and other mutagens. Polymorphism of the SULT gene, is thought to confer susceptibility to upper tract tumours.
Similar articles
- [Sporadic upper urinary tract urothelial cell carcinomas: identification of interaction between toxic carcinogens and individuals genetic susceptibility].
Colin P, Koenig P, Ballereau C, Phé V, Berthon N, Villers A, Biserte J, Rouprêt M. Colin P, et al. Prog Urol. 2010 Jan;20(1):1-10. doi: 10.1016/j.purol.2009.10.010. Epub 2009 Nov 28. Prog Urol. 2010. PMID: 20123521 Review. French. - [Primary upper urinary tract tumors and subsequent location in the bladder].
Azémar MD, Audouin M, Revaux A, Misraï V, Comperat E, Bitker MO, Chartier-Kastler E, Richard F, Cussenot O, Rouprêt M. Azémar MD, et al. Prog Urol. 2009 Oct;19(9):583-8. doi: 10.1016/j.purol.2009.03.007. Epub 2009 May 9. Prog Urol. 2009. PMID: 19800544 Review. French. - [Comparison of upper urinary tract tumors in the region of Balkan nephropathy with those of other regions of Yugoslavia].
Djokic M, Hadzi-Djokic J, Nikolic J, Dragicevic D, Radivojevic D. Djokic M, et al. Prog Urol. 1999 Feb;9(1):61-8. Prog Urol. 1999. PMID: 10212954 French. - [Descriptive and epidemiologic characteristics of patients with malignant upper urothelial tumors in the endemic area of Lazarevac].
Bukvić D, Janković S, Marković-Denić Lj. Bukvić D, et al. Srp Arh Celok Lek. 1999 Nov-Dec;127(11-12):371-5. Srp Arh Celok Lek. 1999. PMID: 10686818 Serbian. - Neoplasms of the upper urinary tract: a review with focus on urothelial carcinoma of the pelvicalyceal system and aspects related to its diagnosis and reporting.
Gupta R, Paner GP, Amin MB. Gupta R, et al. Adv Anat Pathol. 2008 May;15(3):127-39. doi: 10.1097/PAP.0b013e31817145a9. Adv Anat Pathol. 2008. PMID: 18434765 Review.
Cited by
- Contribution of Matrix Metalloproteinase-2 and Matrix Metalloproteinase-9 to Upper Tract Urothelial Cancer Risk in Taiwan.
Wang BR, Ma HH, Chang CH, Liao CH, Chang WS, Mong MC, Yang YC, Gu J, Bau DT, Tsai CW. Wang BR, et al. Life (Basel). 2024 Jun 26;14(7):801. doi: 10.3390/life14070801. Life (Basel). 2024. PMID: 39063556 Free PMC article. - Upper Tract Urothelial Cancer: Guideline of Guidelines.
Pandolfo SD, Cilio S, Aveta A, Wu Z, Cerrato C, Napolitano L, Lasorsa F, Lucarelli G, Verze P, Siracusano S, Quattrone C, Ferro M, Bologna E, Campi R, Del Giudice F, Bertolo R, Amparore D, Palumbo S, Manfredi C, Autorino R. Pandolfo SD, et al. Cancers (Basel). 2024 Mar 11;16(6):1115. doi: 10.3390/cancers16061115. Cancers (Basel). 2024. PMID: 38539450 Free PMC article. Review. - Increased Apolipoprotein A1 Expression Correlates with Tumor-Associated Neutrophils and T Lymphocytes in Upper Tract Urothelial Carcinoma.
Chang CC, Chang CB, Chen CJ, Tung CL, Hung CF, Lai WH, Shen CH, Tsai CY, Lai YY, Lee MY, Wu SF, Chen PC. Chang CC, et al. Curr Issues Mol Biol. 2024 Mar 7;46(3):2155-2165. doi: 10.3390/cimb46030139. Curr Issues Mol Biol. 2024. PMID: 38534755 Free PMC article. - Expression of Basal Compartment and Superficial Markers in Upper Tract Urothelial Carcinoma Associated with Balkan Endemic Nephropathy, a Worldwide Disease.
Jankovic Velickovic L, Ristic Petrovic A, Dolicanin Z, Stojnev S, Velickovic F, Basic D. Jankovic Velickovic L, et al. Biomedicines. 2024 Jan 1;12(1):95. doi: 10.3390/biomedicines12010095. Biomedicines. 2024. PMID: 38255201 Free PMC article. - The Relationship Between PD-1(rs2227981) and PD-L1(rs2890658) Polymorphisms and Urothelial Cell Carcinoma.
Hlaing STM, Damayanti P, Zin Aung K, Tsukino H, Hinoura T, Kuroda Y. Hlaing STM, et al. Cureus. 2023 Nov 1;15(11):e48120. doi: 10.7759/cureus.48120. eCollection 2023 Nov. Cureus. 2023. PMID: 38046711 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous